Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2014 Jan 10;443(2):574-9.
doi: 10.1016/j.bbrc.2013.12.003. Epub 2013 Dec 8.

Genetic Mutations in Adipose Triglyceride Lipase and Myocardial Up-Regulation of Peroxisome Proliferated Activated Receptor-γ in Patients With Triglyceride Deposit Cardiomyovasculopathy

Affiliations
Case Reports

Genetic Mutations in Adipose Triglyceride Lipase and Myocardial Up-Regulation of Peroxisome Proliferated Activated Receptor-γ in Patients With Triglyceride Deposit Cardiomyovasculopathy

Ken-ichi Hirano et al. Biochem Biophys Res Commun. .

Abstract

Adipose triglyceride lipase (ATGL, also known as PNPLA2) is an essential molecule for hydrolysis of intracellular triglyceride (TG). Genetic ATGL deficiency is a rare multi-systemic neutral lipid storage disease. Information regarding its clinical profile and pathophysiology, particularly for cardiac involvement, is still very limited. A previous middle-aged ATGL-deficient patient in our institute (Case 1) with severe heart failure required cardiac transplantation (CTx) and exhibited a novel phenotype, "Triglyceride deposit cardiomyovasculopathy (TGCV)". Here, we tried to elucidate molecular mechanism underlying TGCV. The subjects were two cases with TGCV, including our second case who was a 33-year-old male patient (Case 2) with congestive heart failure requiring CTx. Case 2 was homozygous for a point mutation in the 5' splice donor site of intron 5 in the ATGL, which results in at least two types of mRNAs due to splicing defects. The myocardium of both patients (Cases 1 and 2) showed up-regulation of peroxisome proliferated activated receptors (PPARs), key transcription factors for metabolism of long chain fatty acids (LCFAs), which was in contrast to these molecules' lower expression in ATGL-targeted mice. We investigated the intracellular metabolism of LCFAs under human ATGL-deficient conditions using patients' passaged skin fibroblasts as a model. ATGL-deficient cells showed higher uptake and abnormal intracellular transport of LCFA, resulting in massive TG accumulation. We used these findings from cardiac specimens and cell-biological experiments to construct a hypothetical model to clarify the pathophysiology of the human disorder. In patients with TGCV, even when hydrolysis of intracellular TG is defective, the marked up-regulation of PPARγ and related genes may lead to increased uptake of LCFAs, the substrates for TG synthesis. This potentially vicious cycle of LCFAs could explain the massive accumulation of TG and severe clinical course for this rare disease.

Keywords: ATGL; Adipose triglyceride lipase; BSA; CTx; FCS; GAPDH; HE; LCFA; LSM; LVAS; Long chain fatty acids; MEM; PBS; PCR; PPAR; Peroxisome proliferated activated receptors; TGCV; Triglyceride; Triglyceride deposit cardiomyovasculopathy; adipose triglyceride lipase; bovine serum albumin; cardiac transplantation; fetal calf serum; glyceraldehyde-3-phosphate dehydrogenase; hematoxylin and eosin; laser scanning microscopy; left ventricular assist system; long chain fatty acids; modified Eagle’s medium; peroxisome proliferated activated receptors; phosphate buffered saline; polymerase chain reaction; triglyceride deposit cardiomyovasculopathy.

Similar articles

See all similar articles

Cited by 8 articles

  • Triglyceride deposit cardiomyovasculopathy: a rare cardiovascular disorder.
    Li M, Hirano KI, Ikeda Y, Higashi M, Hashimoto C, Zhang B, Kozawa J, Sugimura K, Miyauchi H, Suzuki A, Hara Y, Takagi A, Ikeda Y, Kobayashi K, Futsukaichi Y, Zaima N, Yamaguchi S, Shrestha R, Nakamura H, Kawaguchi K, Sai E, Hui SP, Nakano Y, Sawamura A, Inaba T, Sakata Y, Yasui Y, Nagasawa Y, Kinugawa S, Shimada K, Yamada S, Hao H, Nakatani D, Ide T, Amano T, Naito H, Nagasaka H, Kobayashi K; Japan TGCV study group. Li M, et al. Orphanet J Rare Dis. 2019 Jun 11;14(1):134. doi: 10.1186/s13023-019-1087-4. Orphanet J Rare Dis. 2019. PMID: 31186072 Free PMC article.
  • Metabolic lipid muscle disorders: biomarkers and treatment.
    Angelini C, Pennisi E, Missaglia S, Tavian D. Angelini C, et al. Ther Adv Neurol Disord. 2019 Apr 22;12:1756286419843359. doi: 10.1177/1756286419843359. eCollection 2019. Ther Adv Neurol Disord. 2019. PMID: 31040882 Free PMC article. Review.
  • Neutral Lipid Storage Diseases as Cellular Model to Study Lipid Droplet Function.
    Missaglia S, Coleman RA, Mordente A, Tavian D. Missaglia S, et al. Cells. 2019 Feb 21;8(2):187. doi: 10.3390/cells8020187. Cells. 2019. PMID: 30795549 Free PMC article. Review.
  • Of mice and men: The physiological role of adipose triglyceride lipase (ATGL).
    Schreiber R, Xie H, Schweiger M. Schreiber R, et al. Biochim Biophys Acta Mol Cell Biol Lipids. 2019 Jun;1864(6):880-899. doi: 10.1016/j.bbalip.2018.10.008. Epub 2018 Oct 25. Biochim Biophys Acta Mol Cell Biol Lipids. 2019. PMID: 30367950 Free PMC article. Review.
  • Generation of induced Pluripotent Stem Cells as disease modelling of NLSDM.
    Tavian D, Missaglia S, Castagnetta M, Degiorgio D, Pennisi EM, Coleman RA, Dell'Era P, Mora C, Angelini C, Coviello DA. Tavian D, et al. Mol Genet Metab. 2017 May;121(1):28-34. doi: 10.1016/j.ymgme.2017.03.009. Epub 2017 Apr 3. Mol Genet Metab. 2017. PMID: 28391974 Free PMC article.
See all "Cited by" articles

Publication types

LinkOut - more resources

Feedback